Burden of metabolic syndrome on primary healthcare costs among older adults: A cross-sectional study
- PMID: 39140580
- PMCID: PMC11318962
- DOI: 10.1590/1516-3180.2023.0215.R1.13052024
Burden of metabolic syndrome on primary healthcare costs among older adults: A cross-sectional study
Abstract
Background: The impact of metabolic syndrome (MetS) on healthcare costs remains unclear in the literature.
Objectives: To determine the impact of MetS on primary healthcare costs of adults, as well as to identify the impact of physical activity and other covariates on this phenomenon.
Design and setting: This cross-sectional study was conducted in the city of Presidente Prudente, State of São Paulo/Brazil, in 2016.
Methods: The sample comprised 159 older adults (> 50 years) of both sexes (110 women) who were identified from their medical records in the Brazilian National Health Service. Healthcare costs (US$) were assessed through medical records and divided into medical consultations, medications, laboratory tests, and total costs. MetS was assessed using medical records.
Results: The Brazilian National Health Service spent more on consultations (US$ 22.75 versus US$ 19.39; + 17.3%) and medication (US$ 19.65 versus US$ 8.32; + 136.1%) among adults with MetS than among those without MetS, but the costs for laboratory tests were similar (P = 0.343). Total costs were 53.9% higher in adults with MetS than in those without the diagnosis of the disease (P = 0.001). Regarding total costs, there was an increase of US$ 38.97 when five components of MetS were present (P = 0.015), representing an increase of approximately 700%, even after adjusting for sex, age, and physical activity.
Conclusion: In conclusion, the presence of the MetS is responsible for increasing primary care costs among older adults, especially in those related to medicines.
Conflict of interest statement
References
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486. - DOI - PubMed
-
- World Health Organization . Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: WHO; 2013. [Accessed in 2018 (Sep. 12)]. Available from: https://www.who.int/publications/i/item/9789241506236 .
-
- Misra A, Misra R, Wijesuriya M, Banerjee D. The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res. 2007;125(3):345–354. - PubMed
-
- World Health Organization . Cardiovascular Diseases. WHO; [Accessed in 2018 (May 20)]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
